The role of nebulised budesonide in the treatment of acute exacerbations of COPD [5]

European Respiratory Journal

Volumn 30, Issue 2, 2007, Pages 399-400

  Gunen, H ^a   Hacievliyagil, S S ^a   Yetkin, O ^a   Gulbas, G ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; C REACTIVE PROTEIN; CORTICOSTEROID; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DECREASED APPETITE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DYSPNEA; FEEDING BEHAVIOR; HOSPITALIZATION; HUMAN; LETTER; MEDICAL RESEARCH; MUSCLE ATROPHY; MUSCLE WEAKNESS; NEBULIZER; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 34547584773     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00047607     Document Type: Letter

References (10)

1. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, In E. The role of nebulised budesonide in the treatment of exacerbations of COPD. Eur Respir J 2007; 29: 660-667.
2. Pinto-Plata VM, Livnat G, Girish M, et al. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007; 131: 37-43.
3. Hansel TT, Barnes PJ. Clinical aspects of COPD. In: Hansel TT, Barnes PJ, eds. An Atlas of Chronic Obstructive Pulmonary Disease. New York, The Parthenon Publishing Group, 2004; pp. 69-115.
4. Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Tenel I. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med 2006; 100: 846-854.
5. Levy ML, Stevenson C, Maslen T. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax 1996; 51: 1087-1092.
6. Westbroek J, Saarelainen S, Laher M, O'Brien J, Barnacle H, Efthimiou J. Oral steroid sparing effect of two doses of nebulized fluticasone and placebo in patients with severe chronic asthma. Respir Med 1999; 93: 689-699.
7. Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir Med 2000; 94: 1206-1214.
8. Morice AH, Morris D, Lawson-Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin Pharmacol Ther 1996; 60: 675-678.
9. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral perdnisolone with placebo in the treatment of acute exacerbations of COPD. Am J Respir Crit Care Med 2002; 165: 698-703.
10. Mirici A, Meral M, Akgun M. Comparison of efficacy of nebulized budesonide with parenteral corticosteroids in the treatment of acute exacerbations of COPD. Clin Drug Invest 2003; 23: 55-62.